Journal of the American Society of Nephrology

Journal

Publication Venue For

  • Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1.  30:2017-2026. 2019
  • Long-term outcomes of arteriovenous fistulas with unassisted versus assisted maturation: A retrospective national hemodialysis cohort study.  30. 2019
  • Erratum: Prediction of arteriovenous fistula clinical maturation from postoperative ultrasound measurements: Findings from the hemodialysis fistula maturation study (Journal of the American Society of Nephrology (2018) 29 (2735-2744)DOI:10.1681/ASN.2017111225).  31:665. 2018
  • A practical guide for treatment of rapidly progressive ADPKD with tolvaptan.  29. 2018
  • Global cardiovascular and renal outcomes of reduced GFR.  28:2167-2179. 2017
  • Sickle cell trait and the risk of ESRD in blacks.  28:2180-2187. 2017
  • Moving beyond minimization trials in kidney transplantation 2015
  • A national study of outcomes among HIV-infected kidney transplant recipients.  2222-2229. 2015
  • Current understanding of the role of complement in IgA nephropathy.  1503-1512. 2015
  • Heme oxygenase-1 regulates myeloid cell trafficking in AKI.  2139-2151. 2015
  • Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials.  160-172. 2015
  • Lack of association of the APOL1 G3 haplotype in African Americans with ESRD.  1021-1025. 2015
  • Reassessing medical risk in living kidney donors.  1017-1019. 2015
  • Characterization of renal toxicity in mice administered the marine biotoxin domoic acid.  1187. 2014
  • The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula 2014
  • Cytomegalovirus and anemia: Not just for transplant anymore.  1613-1615. 2014
  • ABIN1 dysfunction as a genetic basis for lupus nephritis.  24. 2013
  • Imatinib: Novel treatment of immune-mediated kidney injury.  24:694-701. 2013
  • Development of a model of early-onset IgA nephropathy.  23. 2012
  • Induction of IgA deposits and glomerulonephritis by IgA rheumatoid factor.  23:371-373. 2012
  • ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells.  22:2187-2192. 2011
  • Sepsis and acute kidney injury.  22:999-1006. 2011
  • Medicare reimbursement policies and hemodialysis vascular access outcomes: A need for change.  22:426. 2011
  • Immunoglobulin light chains activate tubular epithelial cells through redox signaling.  21:1165-1173. 2010
  • Normal ciliogenesis requires synergy between the cystic kidney disease genes MKS-3 and NPHP-4.  21:782. 2010
  • Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury.  21:1702-1712. 2010
  • Cystin localizes to primary cilia via membrane microdomains and a targeting motif.  2570-2580. 2009
  • Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.  19:2011-2019. 2008
  • Oscillating cortical thick ascending limb cells at the juxtaglomerular apparatus.  19. 2008
  • Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis.  19:1681-1691. 2008
  • Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis.  19:1629-1633. 2008
  • Impact of activated vitamin D and race on survival among hemodialysis patients.  19:1379-1388. 2008
  • Systolic dysfunction portends increased mortality among those waiting for renal transplant.  19:1190-1196. 2008
  • Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.  19:615. 2008
  • Antiproteinuric therapy and fabry nephropathy: Sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-β.  18:2609-2617. 2007
  • Advances in urinary proteome analysis and biomarker discovery.  18:1057-1071. 2007
  • Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study.  18. 2007
  • EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells.  18:131-142. 2007
  • Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.  17:1710-1715. 2006
  • IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease.  16:3651-3660. 2005
  • Towards a definition and classification of acute kidney injury.  16. 2005
  • Connective tissue growth factor (CTGF) N fragment: A marker for progressive diabetic nephropathy..  249A-249A. 2002
  • Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT1 receptors.  1131. 2002
  • Purinergic receptor signaling at the basolateral membrane of macula densa cells.  1145-1151. 2002
  • Renal response to tissue injury: Lessons from heme oxygenase-1 gene ablation and expression.  11. 2000
  • Glycolate metabolism by Hep G2 cells.  10. 1999
  • Temporal Induction of Clusterin in Cisplatin Nephrotoxicity 1997
  • Dominantly transmitted glomerulocystic kidney disease A distinct genetic entity.  77-84. 1997
  • Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation.  1930-1941. 1997
  • Homocysteine and folate concentrations in blood from patients treated with hemodialysis 1996
  • Gene expression of epithelial glucose transporters: the role of diabetes mellitus..  5:S29-S36. 1994
  • Effects of insulin and glucose on renal phosphate reabsorption: Interactions with dietary phosphate.  2:1593. 1992
  • Influence of adenosine receptor blockade on renal function and renal autoregulation.  2:991-999. 1991
  • Albuminuria and racial disparities in the risk for ESRD.  22:1721-1728.
  • Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery.  29:260-267.
  • An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria.  28:494.
  • Angiotensin II stimulates macula densa basolateral sodium/hydrogen exchange via type 1 angiotensin II receptors.  10.
  • Efficacy and safety of renal tubule cell therapy for acute renal failure.  19.
  • Enzyme replacement therapy and fabry kidney disease: Quo vadis?.  18.
  • Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994.  9:853-858.
  • Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.  16:2205-2215.
  • Heme oxygenase-1 gene polymorphisms-toward precision medicine for AKI.  27.
  • Hepatocyte growth factor alters renal epithelial cell susceptibility to uropathogenic Escherichia coli.  12:2543-2553.
  • Klotho and phosphate are modulators of pathologic uremic cardiac remodeling
  • Low socioeconomic status associates with higher serum phosphate irrespective of race.  21:1953-1960.
  • Macula densa nitric oxide synthase 1b protects against salt-sensitive hypertension.  27.
  • Mechanisms of light chain injury along the tubular nephron.  23.
  • Novel paradigms of salt and hypertension.  28.
  • Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption.  24:456.
  • Role of primary cilia in the pathogenesis of polycystic kidney disease.  18:1381-1388.
  • SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function.  28:981-994.
  • The kidney in sarcoidosis.  1555.
  • TβRI independently activates Smad- and CD2AP-dependent pathways in podocytes
  • International Standard Serial Number (issn)

  • 1046-6673
  • Electronic International Standard Serial Number (eissn)

  • 1533-3450